Latest News and Press Releases

WASHINGTON, Dec. 01, 2023 (GLOBE NEWSWIRE) -- The Global Multiple Sclerosis Drugs Market achieved a valuation of $25.90 Billion in 2022 and is anticipated to exceed $34.36 Billion by 2030,...

Pune, India, Aug. 21, 2023 (GLOBE NEWSWIRE) -- The multiple sclerosis drugs market was USD 22.32 billion in 2022 and is anticipated to expand from USD 21.33 billion in 2023 to USD 31.90 billion in...

New York, May 12, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the global Multiple Sclerosis Drugs Market is estimated to be valued at USD 41 Billion by 2032 and is expected to exhibit a CAGR of...

New York, United States, March 08, 2023 (GLOBE NEWSWIRE) -- Multiple sclerosis (MS) is an immune-mediated central nervous system disorder. Demyelination, inflammation, degenerative changes such as...

Pune, Nov. 17, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Growth Plus Reports, the global Multiple Sclerosis Drugs Market will clock US$ 32.7 billion by 2030. The rapidly...

WASHINGTON, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Global multiple sclerosis drugs market size was $25.1 Billion in 2021 and is estimated to generate revenue of $31.2 Billion by 2028 at a CAGR of 3.7%...

Las Vegas, USA, July 06, 2022 (GLOBE NEWSWIRE) -- Multiple Sclerosis Pipeline Insights | Clinical Trials Evaluation Report 2022 | DelveInsight  As per DelveInsight Multiple Sclerosis pipeline...

Pune, India, May 30, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size was worth USD 23.68 billion in 2021. The market valuation is projected to increase from USD 25.43...

Pune, India, April 26, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...

Pune, India, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The global multiple sclerosis drugs market size is set to gain traction as many leading pharmaceutical companies are conducting clinical trials to...